NCT03565393View on ClinicalTrials.gov

Tolerability and Acceptability of Fibersol-2 in Children

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

March 19, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Diarrhea
Interventions
COMBINATION_PRODUCT

Fibersol-2

A placebo-controlled, randomized; double-blind 2 arm trial

Trial Locations (1)

1212

Kumudini Medical College and hospital, Mirzapur, Tangail, Dhaka

All Listed Sponsors
lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

NCT03565393 - Tolerability and Acceptability of Fibersol-2 in Children | Biotech Hunter | Biotech Hunter